These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 21213025)

  • 1. Frozen state storage instability of a monoclonal antibody: aggregation as a consequence of trehalose crystallization and protein unfolding.
    Singh SK; Kolhe P; Mehta AP; Chico SC; Lary AL; Huang M
    Pharm Res; 2011 Apr; 28(4):873-85. PubMed ID: 21213025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frozen-state storage stability of a monoclonal antibody: aggregation is impacted by freezing rate and solute distribution.
    Miller MA; Rodrigues MA; Glass MA; Singh SK; Johnston KP; Maynard JA
    J Pharm Sci; 2013 Apr; 102(4):1194-208. PubMed ID: 23400717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein Aggregation in Frozen Trehalose Formulations: Effects of Composition, Cooling Rate, and Storage Temperature.
    Connolly BD; Le L; Patapoff TW; Cromwell MEM; Moore JMR; Lam P
    J Pharm Sci; 2015 Dec; 104(12):4170-4184. PubMed ID: 26398200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Freeze/thaw of IGG solutions.
    Horn J; Jena S; Aksan A; Friess W
    Eur J Pharm Biopharm; 2019 Jan; 134():185-189. PubMed ID: 30529434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between protein aggregation and molecular mobility below the glass transition temperature of lyophilized formulations containing a monoclonal antibody.
    Duddu SP; Zhang G; Dal Monte PR
    Pharm Res; 1997 May; 14(5):596-600. PubMed ID: 9165529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ReFOLD assay for protein formulation studies and prediction of protein aggregation during long-term storage.
    Svilenov H; Winter G
    Eur J Pharm Biopharm; 2019 Apr; 137():131-139. PubMed ID: 30818009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of glass transition temperature on the stability of lyophilized formulations containing a chimeric therapeutic monoclonal antibody.
    Duddu SP; Dal Monte PR
    Pharm Res; 1997 May; 14(5):591-5. PubMed ID: 9165528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frozen storage of proteins: Use of mannitol to generate a homogenous freeze-concentrate.
    Sonje J; Chisholm CF; Suryanarayanan R
    Int J Pharm; 2023 Jan; 630():121995. PubMed ID: 35809832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increasing storage stability of freeze-dried plasma using trehalose.
    Brogna R; Oldenhof H; Sieme H; Figueiredo C; Kerrinnes T; Wolkers WF
    PLoS One; 2020; 15(6):e0234502. PubMed ID: 32525915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of freezing on pH of buffered solutions and consequences for monoclonal antibody aggregation.
    Kolhe P; Amend E; Singh SK
    Biotechnol Prog; 2010; 26(3):727-33. PubMed ID: 20039442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Computations of Preferential Interaction Coefficients of IgG1 Monoclonal Antibodies with Sorbitol, Sucrose, and Trehalose and the Impact of These Excipients on Aggregation and Viscosity.
    Cloutier T; Sudrik C; Mody N; Sathish HA; Trout BL
    Mol Pharm; 2019 Aug; 16(8):3657-3664. PubMed ID: 31276620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sorbitol crystallization-induced aggregation in frozen mAb formulations.
    Piedmonte DM; Hair A; Baker P; Brych L; Nagapudi K; Lin H; Cao W; Hershenson S; Ratnaswamy G
    J Pharm Sci; 2015 Feb; 104(2):686-97. PubMed ID: 25219372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of Protein Content and Number of Aggregates in Monoclonal Antibody Formulation After Large-Scale Freezing.
    Hauptmann A; Hoelzl G; Loerting T
    AAPS PharmSciTech; 2019 Jan; 20(2):72. PubMed ID: 30631964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Instability of bacteriophages in spray-dried trehalose powders is caused by crystallization of the matrix.
    Vandenheuvel D; Meeus J; Lavigne R; Van den Mooter G
    Int J Pharm; 2014 Sep; 472(1-2):202-5. PubMed ID: 24950368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of Phosphate Buffered Saline (PBS) in Frozen State and after Freeze-Drying.
    Thorat AA; Suryanarayanan R
    Pharm Res; 2019 May; 36(7):98. PubMed ID: 31087169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Excipient Interactions on the State of the Freeze-Concentrate and Protein Stability.
    Jena S; Horn J; Suryanarayanan R; Friess W; Aksan A
    Pharm Res; 2017 Feb; 34(2):462-478. PubMed ID: 27981449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining Unfolding Reversibility Studies and Molecular Dynamics Simulations to Select Aggregation-Resistant Antibodies.
    Berner C; Menzen T; Winter G; Svilenov HL
    Mol Pharm; 2021 Jun; 18(6):2242-2253. PubMed ID: 33928776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystallization of trehalose in frozen solutions and its phase behavior during drying.
    Sundaramurthi P; Patapoff TW; Suryanarayanan R
    Pharm Res; 2010 Nov; 27(11):2374-83. PubMed ID: 20811935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accelerated Aggregation Studies of Monoclonal Antibodies: Considerations for Storage Stability.
    Wälchli R; Vermeire PJ; Massant J; Arosio P
    J Pharm Sci; 2020 Jan; 109(1):595-602. PubMed ID: 31676272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of local mobility in aggregation of beta-galactosidase lyophilized with trehalose, sucrose or stachyose.
    Yoshioka S; Miyazaki T; Aso Y; Kawanishi T
    Pharm Res; 2007 Sep; 24(9):1660-7. PubMed ID: 17404806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.